Amir Mortazavi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma (NCT01129193) | Amir Mortazavi | 2010-05-04 |
Track Amir Mortazavi automatically
Every clearance here is in the API, with alerts when new ones post.